Israel-based Trendlines, which is listed on the SGX, will receive net proceeds of US$15.8 million for its 26.9% stake.
The Trendlines Group has divested its stake in one of its portfolio companies focusing on orthopedics to Synthes, a subsidiary of Johnson & Johnson.
The portfolio company, OrthoSpin, is sold to the US healthcare giant for US$79.5 million.
![[19/05/26] new top stories](/_next/image?url=https%3A%2F%2Fedgemarkets-transferred.s3-ap-southeast-1.amazonaws.com%2FPEO_KUNHEE_PARK_01_AC_2.jpg%3FTd3bG7fJqxPW3hMZRxhyfGgI25yRRD5v&w=640&q=75)
